According to GlobalData’s medical device pipeline database, 67 Synthetic Bone Graft Substitutes devices are in various stages of development globally. GlobalData’s report Synthetic Bone Graft Substitutes provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 19 are in active development, while the remaining 48 are in an inactive stage of development. There are eight products in the early stages of development, and the remaining 11 are in the late stages of development.
Synthetic bone graft substitutes are used as substitutes to autograft and allograft bone. Major types of synthetic bone substitutes include calcium sulfate, calcium phosphate, tricalcium phosphate (TCP), and coralline hydroxyapatite. The second-generation products include bioactive glass, collagen-containing and polymer-based bone substitutes. Products available in the form of granules, paste, pellets or strips are all tracked here. One unit volume is 10ml of synthetic bone substitutes.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Synthetic Bone Graft Substitutes pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Synthetic Bone Graft Substitutes devices. Overall, most of these Synthetic Bone Graft Substitutes pipeline devices are being developed by private entities.
Key players involved in the active development of Synthetic Bone Graft Substitutes include Bone Solutions, Bio2 Technologies, BioGend Therapeutics, BoneSupport, OssDsign, RepRegen, Graftys, Anika Therapeutics, Berkeley Advanced Biomaterials and Sofregen Medical.
For a complete picture of the developmental pipeline for Synthetic Bone Graft Substitutes devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.